Drugs / Aluminum Hydroxide Suspension
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06680479 Background | Apr 2025 → Apr 2027 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aluminum Hydroxide Suspension | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06680479 ↗ |